表紙
市場調查報告書
商品編碼
1045336

體外毒性測試:技術和全球市場

In Vitro Toxicity Testing: Technologies and Global Markets

出版日期: | 出版商: BCC Research | 英文 228 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球體外毒性測試市場預計在 2021 年增長到 90 億美元,從 2021 年到 2026 年以 8.3% 的複合年增長率增長,到 2026 年達到 133 億美元。

本報告探討了全球體外毒性測試市場、市場概況、市場驅動因素和抑制因素分析、市場機會、COVID-19 影響、毒性終點和通過測試,它提供了設備等系統信息/主要公司的技術、組件、最終用戶、區域市場分析、競爭形勢和概況。

目錄

第1章介紹

  • 調查目標和目的
  • 進行調查的原因
  • 更新點
  • 報告範圍
  • 信息來源
  • 調查方法
  • 地理分佈
  • 分析師生涯
  • BCC 自定義調查
  • 相關 BCC 調查報告

第2章總結與重點

第3章市場與技術背景

  • 簡介

第 4 章監管框架和計劃

  • 醫療器械的定義和分類
  • 規則
  • 美國
  • 歐洲
  • 監管時間表

第五章市場動態

  • 市場動態
  • 市場促進因素
  • 市場製約因素
  • 市場機會

第 6 章 COVID-19 大流行的影響

  • 簡介
  • 出現
  • COVID-19 的症狀
  • COVID-19 的進展
  • 孵化期
  • 流行病學
  • 全球確診的 COVID-19 病例和死亡病例
  • 協作
  • 疾病的侵擾
  • 現狀及對 Medtech 的影響
  • 選擇性和無關緊要的處理
  • 製造轉移
  • 延遲監管、臨床試驗和產品上市
  • 供應鏈中斷
  • 醫療旅遊
  • 政府和私人資金
  • 用於診斷套件和設備的 EUA
  • COVID-19:疫苗開發的全球展望

第 7 章市場細分:毒性終點和測試

  • 毒性終點和全球市場研究
  • 市場規模和預測
  • ADME
  • 基因毒性試驗
  • 細胞毒性試驗
  • 眼毒性
  • 器官毒性
  • 皮膚刺激、腐蝕和致敏
  • 光毒性試驗
  • 皮膚毒性
  • 致癌
  • 神經毒性
  • 發育和生殖毒性 (DART)
  • 其他

第 8 章市場細分:按設備/技術

  • 按設備/技術劃分的全球市場
  • 市場規模和預測
  • 轉錄組混合
  • 蛋白質組學
  • 代謝組學
  • 細胞組學或細胞組學

第 9 章市場細分:按組件

  • 按組件劃分的全球市場
  • 市場規模和預測
  • 設備
  • 試劑和試劑盒
  • 軟件和分析
  • 服務

第 10 章市場細分:按最終用戶分類

  • 按最終用戶劃分的全球市場
  • 市場規模和預測
  • 製藥和生物技術
  • 食品飲料行業
  • 醫療保健(診斷)
  • 化學工業
  • CRO
  • 研究調查
  • 個人護理用品(化妝品)

第 11 章市場細分:按地區

  • 按地區劃分的全球市場
  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第12章競爭態勢

  • 體外毒性試驗
  • 全球公司份額分析
  • 市場公司

第13章公司簡介

  • Key Players
  • ABBOTT LABORATORIES, INC.
  • AGILENT TECHNOLOGIES INC.
  • GE HEALTHCARE
  • PERKINELMER INC.
  • QIAGEN NV
  • THERMO FISHER SCIENTIFIC INC.
  • Other Market Players
  • ACEA BIOSCIENCES INC.
  • ALBANY MOLECULAR RESEARCH INC.
  • APTUIT INC.
  • BIOGNOSYS AG
  • BIORELIANCE
  • BIOVIA
  • CELLULAR DYNAMICS INTERNATIONAL INC.
  • CHANTEST
  • CHARLES RIVER LABORATORIES
  • COVANCE INC.
  • CYPROTEX PLC
  • DRIK LLC
  • ENZO LIFE SCIENCES INC.
  • ESSEN BIOSCIENCE INC.
  • EUROFINS SCIENTIFIC SE
  • EVOTEC AG
  • GENEDATA
  • GENTRONIX LTD.
  • HUREL CORP.
  • IMQUEST BIOSCIENCES INC.
  • IMSTAR SA
  • INSPHERO AG
  • KIYATEC INC.
  • LONZA GROUP LTD.
  • METABOLON INC.
  • MOLECULAR DEVICES LLC
  • PROMEGA CORP.
  • SGS-SA
  • STEMINA BIOMARKER DISCOVERY INC.
  • SYNVIVO, INC.
  • VALA SCIENCES INC.
  • VISTAGEN THERAPEUTICS INC.
  • XENOMETRIX AG

第14章附錄:縮略語列表

目錄
Product Code: PHM017G

Highlights:

The global in vitro toxicity testing market should reach $13.3 billion by 2026 from $9.0 billion in 2021 at a compound annual growth rate (CAGR) of 8.3% for the forecast period of 2021 to 2026.

The ADME segment of the global in vitro toxicity testing market is expected to grow from $2.6 billion in 2021 to $4.2 billion in 2026 at a CAGR of 9.8% for the forecast period of 2021 to 2026.

The cytotoxicity testing segment of the global in vitro toxicity testing market is expected to grow from $1.3 billion in 2021 to $2.0 billion in 2026 at a CAGR of 8.2% for the forecast period of 2021 to 2026.

Report Scope:

This report examines the current and future market potential of In Vitro Toxicity Testing Technologies. It offers a detailed analysis of the competitive environment, the regulatory scenario, technological advancements, drivers, restraints, opportunity and trends in market growth. This report covers market projections through 2026 and market rank for key market players. The report details the market shares of In Vitro Toxicity Testing Technologies segmented by toxicity endpoints and tests, tools/technology, components and end users.

This report segments the global market by geographic region: North America, Europe, Asia-Pacific and the Rest of the world. The North American region includes the U.S., Canada and Mexico, the European region (including Germany, U.K., France and the Rest of Europe), the Asia-Pacific region (including China, India, Japan and the Rest of Asia-Pacific). For market estimates, data is provided for the year 2019-2020 as the base year and forecast through year-end, 2026.

Report Includes:

  • 132 data tables and 30 additional tables
  • An updated review of the global markets for in vitro toxicity testing and technologies under development
  • Analyses of the global market trends, with data from 2019 to 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Technology assessment of the key drivers, restraints and opportunities that will shape the market for in vitro toxicity testing over the next five years (2021 to 2026)
  • Evaluation and forecast the overall market size, and corresponding market share analysis by toxicity endpoints and tests, tool/technology, component, end-user industry and geographic region
  • Highlights of COVID-19 implications on the progress of this market
  • Country specific data and market value analysis for the U.S., Canada, Mexico, Germany, U.K., France, Japan, China and India
  • Review of key technology developments, latest market trends, and other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics and chemicals
  • Insight into recent industry structure, current competitive landscape, R&D activities, and regulatory and legislative issues currently focused on in vitro toxicology testing
  • Descriptive company profiles of the leading market players, including Abbott Laboratories Inc., GE Healthcare, PerkinElmer Inc., Qiagen NV and Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • What's New in This Update
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Introduction

Chapter 4 Regulatory Framework and Programs

  • Medical Device Definition and Classification
  • Regulations
  • U.S.
  • Europe
  • Regulatory Timeline

Chapter 5 Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Market Restraints
  • Opportunities

Chapter 6 Impact of COVID-19 Pandemic

  • Introduction
  • Outbreak
  • Symptoms of COVID-19
  • Progression of COVID-19
  • Incubation Period
  • Epidemiology
  • Global Confirmed COVID-19 Cases and Deaths
  • Collaboration
  • Spread of Disease
  • Current Status and Impact on Medtech
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism
  • Government and Private Funds
  • EUA for Diagnostic Kits and Devices
  • COVID-19: Global Landscape of Vaccine Development

Chapter 7 Market Breakdown by Toxicity Endpoint and Test

  • Global Market for In Vitro Toxicity by Toxicity Endpoint and Test
  • Market Size and Forecast
  • ADME
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Skin Irritation, Corrosion and Sensitization
  • Phototoxicity Testing
  • Dermal Toxicity
  • Carcinogenicity
  • Neurotoxicity
  • Development and Reproductive Toxicity (DART)
  • Other Toxicity Endpoints and Tests

Chapter 8 Market Breakdown by Tool/Technology

  • Global Market for In Vitro Toxicity by Tool/Technology
  • Market Size and Forecast
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Cellomics or Cytomics

Chapter 9 Market Breakdown by Component

  • Global Market for In Vitro Toxicity Testing Technology by Component
  • Market Size and Forecast
  • Equipment
  • Reagents and Kits
  • Software and Analytics
  • Services

Chapter 10 Market Breakdown by End User

  • Global Market for In Vitro Toxicity Testing by End User
  • Market Size and Forecast
  • Pharmaceutical and Biotechnology
  • Food and Beverage Industry
  • Healthcare (Diagnosis)
  • Chemical Industry
  • CROs
  • Research Institutes
  • Personal Care Products (Cosmetics)

Chapter 11 Market Breakdown by Region

  • Global Market for In Vitro Toxicity Testing by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 12 Competitive Landscape

  • In Vitro Toxicity Testing
  • Global Company Share Analysis
  • In Vitro Toxicity Testing Market Players

Chapter 13 Company Profiles

  • Key Players
  • ABBOTT LABORATORIES, INC.
  • AGILENT TECHNOLOGIES INC.
  • GE HEALTHCARE
  • PERKINELMER INC.
  • QIAGEN NV
  • THERMO FISHER SCIENTIFIC INC.
  • Other Market Players
  • ACEA BIOSCIENCES INC.
  • ALBANY MOLECULAR RESEARCH INC.
  • APTUIT INC.
  • BIOGNOSYS AG
  • BIORELIANCE
  • BIOVIA
  • CELLULAR DYNAMICS INTERNATIONAL INC.
  • CHANTEST
  • CHARLES RIVER LABORATORIES
  • COVANCE INC.
  • CYPROTEX PLC
  • DRIK LLC
  • ENZO LIFE SCIENCES INC.
  • ESSEN BIOSCIENCE INC.
  • EUROFINS SCIENTIFIC SE
  • EVOTEC AG
  • GENEDATA
  • GENTRONIX LTD.
  • HUREL CORP.
  • IMQUEST BIOSCIENCES INC.
  • IMSTAR SA
  • INSPHERO AG
  • KIYATEC INC.
  • LONZA GROUP LTD.
  • METABOLON INC.
  • MOLECULAR DEVICES LLC
  • PROMEGA CORP.
  • SGS-SA
  • STEMINA BIOMARKER DISCOVERY INC.
  • SYNVIVO, INC.
  • VALA SCIENCES INC.
  • VISTAGEN THERAPEUTICS INC.
  • XENOMETRIX AG

Chapter 14 Appendix: List of Acronyms

List of Tables

  • Summary Table A : Global Market for In Vitro Toxicity Testing, Through 2026
  • Summary Table B : Global Market for In Vitro Toxicity Testing, by Toxicity Endpoint and Test, Through 2026
  • Summary Table C : Global Market for In Vitro Toxicity Testing, by Tools, Through 2026
  • Summary Table D : Global Market for In Vitro Toxicity Testing, by Component, Through 2026
  • Summary Table E : Global Market for In Vitro Toxicity Testing, by End User, Through 2026
  • Table 1 : Class I and Class II Exempt Devices
  • Table 2 : Timeline: Cosmetic Testing on Animals
  • Table 3 : In Vitro versus In Vivo Toxicity Models
  • Table 4 : Research Institutes/Organizations in In Vitro Testing and Other Services
  • Table 5 : BioReliance (Merck) Toxicology Services
  • Table 6 : CROs Providing In Vitro Toxicity Services
  • Table 7 : Instruments, In Vitro Toxicology Testing, 2019
  • Table 8 : Health Spending Per Capita
  • Table 9 : COVID-19 Clinical Symptoms
  • Table 10 : COVID-19 Confirmed Cases and Deaths, by Country, Oct. 28, 2021
  • Table 11 : Test Kit Manufacturers and EUA
  • Table 12 : Number of COVID Vaccines in Clinical Development, Nov. 26, 2021
  • Table 13 : Number of COVID Vaccines in Phase I Clinical Trials, Nov. 26, 2021
  • Table 14 : Number of COVID Vaccines in Phase I/II Clinical Trials, Nov. 26, 2021
  • Table 15 : Number of COVID Vaccines in Phase I/II Clinical Trials, Nov. 26, 2021
  • Table 16 : Number of COVID Vaccines in Phase II/III Clinical Trials, Nov. 26, 2021
  • Table 17 : Number of COVID Vaccines in Phase III Clinical Trials, Nov. 26, 2021
  • Table 18 : Number of COVID Vaccines in Phase IV Clinical Trials, Nov. 26, 2021
  • Table 19 : Candidate Vaccines in Pre-clinical Development, Nov. 26, 2021
  • Table 20 : Global Market for In Vitro Toxicology Testing Technologies, by Toxicity Endpoint and Test, Through 2026
  • Table 21 : Global Market for ADME, by Region, Through 2026
  • Table 22 : North American Market for ADME, by Country, Through 2026
  • Table 23 : European Market for ADME, by Country, Through 2026
  • Table 24 : Asia-Pacific Market for ADME, by Country, Through 2026
  • Table 25 : ADME In Vitro Toxicity Products
  • Table 26 : Global Market for Genotoxicity Testing, by Region, Through 2026
  • Table 27 : North American Market for Genotoxicity Testing, by Country, Through 2026
  • Table 28 : European Market for Genotoxicity Testing, by Country, Through 2026
  • Table 29 : Asia-Pacific Market for Genotoxicity Testing, by Country, Through 2026
  • Table 30 : Genotoxicity Testing Products
  • Table 31 : Global Market for Cytotoxicity Testing, by Region, Through 2026
  • Table 32 : North American Market for Cytotoxicity Testing, by Country, Through 2026
  • Table 33 : European Market for Cytotoxicity Testing, by Country, Through 2026
  • Table 34 : Asia-Pacific Market for Cytotoxicity Testing, by Country, Through 2026
  • Table 35 : Global Market for Ocular Toxicity Testing, by Region, Through 2026
  • Table 36 : North American Market for Ocular Toxicity Testing, by Country, Through 2026
  • Table 37 : European Market for Ocular Toxicity Testing, by Country, Through 2026
  • Table 38 : Asia-Pacific Market for Ocular Toxicity Testing, by Country, Through 2026
  • Table 39 : Global Market for Organ Toxicity Testing, by Region, Through 2026
  • Table 40 : North American Market for Organ Toxicity Testing, by Country, Through 2026
  • Table 41 : European Market for Organ Toxicity Testing, by Country, Through 2026
  • Table 42 : Asia-Pacific Market for Organ Toxicity Testing, by Country, Through 2026
  • Table 43 : Global Market for Skin Irritation, Corrosion and Sensitization Testing, by Region, Through 2026
  • Table 44 : North American Market for Skin Irritation, Corrosion and Sensitization Testing, by Country, Through 2026
  • Table 45 : European Market for Skin Irritation, Corrosion and Sensitization Testing, by Country, Through 2026
  • Table 46 : Asia-Pacific Market for Skin Irritation, Corrosion and Sensitization Testing, by Country, Through 2026
  • Table 47 : Global Market for Phototoxicity Testing, by Region, Through 2026
  • Table 48 : North American Market for Phototoxicity Testing, by Country, Through 2026
  • Table 49 : European Market for Phototoxicity Testing, by Country, Through 2026
  • Table 50 : Asia-Pacific Market for Phototoxicity Testing, by Country, Through 2026
  • Table 51 : Validated Non-Animal Methods
  • Table 52 : Global Market for In Vitro Toxicology Testing by Dermal Toxicity, by Region, Through 2026
  • Table 53 : North American Market for Dermal Toxicity Testing, by Country, Through 2026
  • Table 54 : European Market for Dermal Toxicity, by Country, Through 2026
  • Table 55 : Asia-Pacific Market for Dermal Toxicity Testing, by Country, Through 2026
  • Table 56 : Global Market for Carcinogenicity Testing, by Region, Through 2026
  • Table 57 : North American Market for Carcinogenicity Testing, by Country, Through 2026
  • Table 58 : European Market for Carcinogenicity Testing, by Country, Through 2026
  • Table 59 : Asia-Pacific Market for Carcinogenicity Testing, by Country, Through 2026
  • Table 60 : OECD TGs for In Vitro Genotoxicity and Mutagenicity Testing
  • Table 61 : Global Market for Neurotoxicity Testing, by Region, Through 2026
  • Table 62 : North American Market for Neurotoxicity Testing, by Country, Through 2026
  • Table 63 : European Market for Neurotoxicity Testing, by Country, Through 2026
  • Table 64 : Asia-Pacific Market for Neurotoxicity Testing, by Country, Through 2026
  • Table 65 : Endpoints, In Vitro Neurotoxicity Testing
  • Table 66 : Global Market for DART, by Region, Through 2026
  • Table 67 : North American Market for DART, by Country, Through 2026
  • Table 68 : European Market for DART, by Country, Through 2026
  • Table 69 : Asia-Pacific Market for DART, by Country, Through 2026
  • Table 70 : Global Market for Other types of In Vitro Toxicology Testing, by Region, Through 2026
  • Table 71 : North American Market for Other Types of In Vitro Toxicology Testing, by Country, Through 2026
  • Table 72 : European Market for Other Types of In Vitro Toxicology Testing, by Country, Through 2026
  • Table 73 : Asia-Pacific Market for Other Types of In Vitro Toxicology Testing, by Country, Through 2026
  • Table 74 : In Vitro Acute Inhalation Toxicity
  • Table 75 : Global Market for In Vitro Toxicology Testing Technologies, by Tool/Technology, Through 2026
  • Table 76 : Global Market for Transcriptomics, by Region, Through 2026
  • Table 77 : North American Market for Transcriptomics, by Country, Through 2026
  • Table 78 : European Market for Transcriptomics, by Country, Through 2026
  • Table 79 : Asia-Pacific Market for Transcriptomics, by Country, Through 2026
  • Table 80 : Global Market for Proteomics, by Region, Through 2026
  • Table 81 : North American Market for Proteomics, by Country, Through 2026
  • Table 82 : European Market for Proteomics, by Country, Through 2026
  • Table 83 : Asia-Pacific Market for Proteomics, by Country, Through 2026
  • Table 84 : Global Market for Metabolomics, by Region, Through 2026
  • Table 85 : North American Market for Metabolomics, by Country, Through 2026
  • Table 86 : European Market for Metabolomics, by Country, Through 2026
  • Table 87 : Asia-Pacific Market for Metabolomics, by Country, Through 2026
  • Table 88 : Use of Metabolomics Toxicology
  • Table 89 : Common Analytical Platforms, Metabolomics
  • Table 90 : Global Market for Cellomics, by Region, Through 2026
  • Table 91 : North American Market for Cellomics, by Country, Through 2026
  • Table 92 : European Market for Cellomics, by Country, Through 2026
  • Table 93 : Asia-Pacific Market for Cellomics, by Country, Through 2026
  • Table 94 : Global Market for In Vitro Toxicity Testing, by Component Type, Through 2026
  • Table 95 : Global Market for In Vitro Toxicity Testing Equipment, by Region, Through 2026
  • Table 96 : North American Market for In Vitro Toxicity Testing Equipment, by Country, Through 2026
  • Table 97 : European Market for In Vitro Toxicity Testing Equipment, by Country, Through 2026
  • Table 98 : Asia-Pacific Market for In Vitro Toxicity Testing Equipment, by Country, Through 2026
  • Table 99 : Global Market for In Vitro Toxicity Testing Reagents and Kits, by Region, Through 2026
  • Table 100 : North American Market for In Vitro Toxicity Testing Reagents and Kits, by Country, Through 2026
  • Table 101 : European Market for In Vitro Toxicity Testing Reagents and Kits, by Country, Through 2026
  • Table 102 : Asia-Pacific Market for In Vitro Toxicity Testing Reagents and Kits, by Country, Through 2026
  • Table 103 : Specifications of HCS LIVE/DEAD Green Kit
  • Table 104 : Global Market for In Vitro Toxicity Testing Software and Analytics, by Region, Through 2026
  • Table 105 : North American Market for In Vitro Toxicity Testing Software and Analytics, by Country, Through 2026
  • Table 106 : European Market for In Vitro Toxicity Testing Software and Analytics, by Country, Through 2026
  • Table 107 : Asia-Pacific Market for In Vitro Toxicity Testing Software and Analytics, by Country, Through 2026
  • Table 108 : Features of TraceFinder Software
  • Table 109 : Global Market for In Vitro Toxicity Testing Services, by Region, Through 2026
  • Table 110 : North American Market for In Vitro Toxicity Testing Services, by Country, Through 2026
  • Table 111 : European Market for In Vitro Toxicity Testing Services, by Country, Through 2026
  • Table 112 : Asia-Pacific Market for In Vitro Toxicity Testing Services, by Country, Through 2026
  • Table 113 : Global Market for In Vitro Toxicity Testing, by End User, Through 2026
  • Table 114 : Global Market for In Vitro Toxicity Testing by Pharmaceutical and Biotechnology End Users, by Region, Through 2026
  • Table 115 : North American Market for In Vitro Toxicity Testing by Pharmaceutical and Biotechnology End Users, by Country, Through 2026
  • Table 116 : European Market for In Vitro Toxicity Testing by Pharmaceutical and Biotechnology End Users, by Country, Through 2026
  • Table 117 : Asia-Pacific Market for In Vitro Toxicity Testing by Pharmaceutical and Biotechnology End Users, by Country, Through 2026
  • Table 118 : Global Market for In Vitro Toxicity Testing by Food and Beverage Industry End Users, by Region, Through 2026
  • Table 119 : North American Market for In Vitro Toxicity Testing by Food and Beverage Industry End Users, by Country, Through 2026
  • Table 120 : European Market for In Vitro Toxicity Testing by Food and Beverage Industry End Users, by Country, Through 2026
  • Table 121 : Asia-Pacific Market for In Vitro Toxicity Testing by Food and Beverage Industry End Users, by Country, Through 2026
  • Table 122 : Global Market for In Vitro Toxicity Testing by Healthcare End Users, by Region, Through 2026
  • Table 123 : North American Market for In Vitro Toxicity Testing by Healthcare End Users, by Country, Through 2026
  • Table 124 : European Market for In Vitro Toxicity Testing by Healthcare End Users, by Country, Through 2026
  • Table 125 : Asia-Pacific Market for In Vitro Toxicity Testing by Healthcare End Users, by Country, Through 2026
  • Table 126 : Global Market for In Vitro Toxicity Testing by Chemical Industry End Users, by Region, Through 2026
  • Table 127 : North American Market for In Vitro Toxicity Testing by Chemical Industry End Users, by Country, Through 2026
  • Table 128 : European Market for In Vitro Toxicity Testing by Chemical Industry End Users, by Country, Through 2026
  • Table 129 : Asia-Pacific Market for In Vitro Toxicity Testing by Chemical Industry End Users, by Country, Through 2026
  • Table 130 : Selected In Vitro Toxicology Services
  • Table 131 : Global Market for In Vitro Toxicity Testing by Contract Research Organization End Users, by Region, Through 2026
  • Table 132 : North American Market for In Vitro Toxicity Testing by Contract Research Organization End Users, by Country, Through 2026
  • Table 133 : European Market for In Vitro Toxicity Testing by Contract Research Organization End Users, by Country, Through 2026
  • Table 134 : Asia-Pacific Market for In Vitro Toxicity Testing by Contract Research Organization End Users, by Country, Through 2026
  • Table 135 : Selected In Vitro Toxicology Service CROs
  • Table 136 : Global Market for In Vitro Toxicity Testing by Research Institute End Users, by Region, Through 2026
  • Table 137 : North American Market for In Vitro Toxicity Testing by Research Institute End Users, by Country, Through 2026
  • Table 138 : European Market for In Vitro Toxicity Testing by Research Institute End Users, by Country, Through 2026
  • Table 139 : Asia-Pacific Market for In Vitro Toxicity Testing by Research Institute End Users, by Country, Through 2026
  • Table 140 : Research Institutes Involved In Vitro Toxicology Tests
  • Table 141 : Global Market for In Vitro Toxicity Testing of Personal Care Products, by Region, Through 2026
  • Table 142 : North American Market for In Vitro Toxicity Testing of Personal Care Products, by Country, Through 2026
  • Table 143 : European Market for In Vitro Toxicity Testing of Personal Care Products, by Country, Through 2026
  • Table 144 : Asia-Pacific Market for In Vitro Toxicity Testing of Personal Care Products, by Country, Through 2026
  • Table 145 : Global Market for In Vitro Toxicity Testing, by Region, Through 2026
  • Table 146 : North American Market for In Vitro Toxicity Testing, by Country, Through 2026
  • Table 147 : European Market for In Vitro Toxicity Testing, by Country, Through 2026
  • Table 148 : Asia-Pacific Market for In Vitro Toxicity Testing, by Country, Through 2026
  • Table 149 : Global Market Shares of In Vitro Toxicity Testing, by Manufacturer, 2020
  • Table 150 : Abbott Laboratories: Net Revenue, 2018-2020
  • Table 151 : Abbott Laboratories: Products and Services
  • Table 152 : Agilent Technologies Inc.: Net Revenue, 2018-2020
  • Table 153 : PerkinElmer: Product Portfolio
  • Table 154 : Qiagen NV: Financials, 2018-2020
  • Table 155 : Qiagen NV: Products and Services
  • Table 156 : Thermo Fisher Scientific: Products and Services
  • Table 157 : Acronyms Used in the In Vitro Toxicity Testing Industry

List of Figures

  • Figure 1 : Marketing a Medical Device in the U.S.
  • Figure 2 : Discovery Toxicology
  • Figure 3 : Global Market Shares of In Vitro Toxicology Testing, by Toxicity Endpoint and Test, 2020
  • Figure 4 : Global Market Shares of In Vitro Toxicology Testing, by Tool/Technology, 2020
  • Figure 5 : Drug Discovery Process
  • Figure 6 : Global Market Shares of In Vitro Toxicity Testing, by Component Type, 2020
  • Figure 7 : Global Market Shares of In Vitro Toxicity Testing, by End User, 2020
  • Figure 8 : Global Market Shares of In Vitro Toxicity Testing, by Region, 2020
  • Figure 9 : North American Market Shares of In Vitro Toxicity Testing, by Country, 2020
  • Figure 10 : U.S. Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 11 : Canadian Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 12 : Mexican Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 13 : European Market Shares of In Vitro Toxicity Testing, by Country, 2020
  • Figure 14 : German Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 15 : U.K. Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 16 : French Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 17 : Rest of European Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 18 : Asia-Pacific Market Shares of In Vitro Toxicity Testing, by Country, 2020
  • Figure 19 : Japanese Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 20 : Chinese Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 21 : Indian Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 22 : Rest of Asia-Pacific Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 23 : Rest of the World Market for In Vitro Toxicity Testing, 2019-2026
  • Figure 24 : Abbott Laboratories: Sales Share, by Segment, 2020
  • Figure 25 : Abbott Laboratories: Sales Share, by Country, 2020
  • Figure 26 : Agilent Technologies Inc.: Sales Share, by Segment, 2020
  • Figure 27 : Agilent Technologies Inc.: Net Revenue Share, by Operations, 2020
  • Figure 28 : Agilent Technologies Inc.: Sales Share, by Region, 2020
  • Figure 29 : GE: Annual Revenue, 2019 and 2020
  • Figure 30 : GE: Revenue Share, by Product Category, 2020
  • Figure 31 : PerkinElmer: Annual Revenue, 2018-2020
  • Figure 32 : PerkinElmer: Revenue Share, by Business Segment, 2020
  • Figure 33 : PerkinElmer: Revenue Share, by Revenue Type, 2020
  • Figure 34 : PerkinElmer: Revenue Share, by Region, 2020
  • Figure 35 : Qiagen NV: Net Sales Share, by Region, 2020
  • Figure 36 : Qiagen NV: Net Sales Share, by Product Type, 2020
  • Figure 37 : Qiagen NV: Net Sales Share of COVID-19 and Non-COVID-19 Products, 2020
  • Figure 38 : Qiagen NV: Net Sales Share, by Customer Class, 2020
  • Figure 39 : Qiagen NV: Net Sales Share, by Product Group, 2020
  • Figure 40 : Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
  • Figure 41 : Thermo Fisher Scientific: Revenue Share, by Product Category, 2020
  • Figure 42 : Thermo Fisher Scientific: Revenue Share, by Region, 2020
  • Figure 43 : Thermo Fisher Scientific: Revenue Share, by Market, 2020